We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept


Lesvi's product portfolio comprises CNS pharmaceuticals and nutraceuticals, unique dosage forms and products in other therapeutic areas such as antiemetic, anti-infective, cardiovascular, diseases and pain. 
Product Active Ingredients Dosage form Description Launch date
Noxiall® PEA + Commiphora  Myrrha + Rosmarinus Officinalis + Piper Nigrum (of which Beta Caryophyllene) Box of 20 tablets Useful to contrast chronic and neuropathic pain Jan 2017
Partnena® Magnesium + Parthenium + Andrographis Paniculata + Coenzyme Q10 + Vitamin B2 Box of 28 tablets Rational combination for the prophylaxis of migraine, the nociceptive modulation and the reduction of tension states Jan 2014
Quetidia® L-Theanine + Passiflora + Skullcap + Magnesium Box of 30 tablets Useful for the management of anxiety disorders Sep 2014
Quetidia® oral solution L-Theanine + Passiflora + Skullcap + Magnesium Oral solution. Bottle of 150 ml Useful for the management of anxiety disorders Sep 2017
Seripnol® L-Theanine + Magnolia + Ziziphus + Melatonin Box of 28 sachets Useful to promote relaxation and sleep Mar 2012
Seripnol® drops L-Theanine + Melatonin + Magnolia + Ziziphus Oral drops. Bottle of 30 ml Useful to promote relaxation and sleep Apr 2014

Triadenor® N-Acetyl-Cystein + S-Adenosyl -LMethionine + Folic Acid Box of 16 tablets Useful for the management of depressive disorders Nov 2014
UMP + Folic Acid + B12 Uridine Monophosphate + Folic Acid + Vitamin B12 Box of 20 and 40 film-coated tablets Useful for the treatment of spinal syndromes, neuralgias and polyneuropathies Jul 2018
Vivifast® Citicoline Cognizin® +  Homotaurine + Vitamin E Box of 20 tablets Useful in the management of several types of cognitive disorders Nov 2015
Viviflux® Homotaurine + DHA + Folic Acid Box of 20 capsules Indicated for stroke primary and secondary prevention and for cerebrovascular disorders Sep 2011
Vivimind® Homotaurine Box of 40 tablets Intended to protect memory and cognitive functions in MCI patients Nov 2010

[*] Differentiated product
[**] Opioid

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.